A

Amgen

Makes biotech medicines for serious illnesses

Senior Data Scientist - Perturbation Biology & AI

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeHyderabad, Telangana, IndiaNo salary listedIn-person

About the Job

Requirements

  • Any degree and 8–13 years of directly related experience.
  • Demonstrated expertise in method development for functional genomics and perturbation screens, ideally with experience in single-cell omics technologies.
  • Strong background in machine learning and artificial intelligence, including deep learning, generative modeling, and transformer-based architectures; experience with pre-training, fine-tuning, and few-shot or zero-shot learning, ideally with in silico modeling of cellular responses to drug or genetic perturbations.
  • Proven track record of applying computational methods to drive biological insights, target validation, biomarker discovery, or therapeutic hypothesis generation.
  • Proficiency in scientific programming languages and tool development using Python, R, or similar, with familiarity in relevant libraries and frameworks.
  • Experience with large-scale data processing using cloud computing, workflow development, and software best practices such as version control, continuous integration, and test-driven development.
  • Familiarity with agentic artificial intelligence, digital innovation approaches, and FAIR data principles for building robust and scalable analytical workflows.
  • Familiarity with molecular and disease biology, with the ability to contextualize computational findings in therapeutic discovery.
  • Analytical and communication skills to extract and clearly present insights from complex data to diverse audiences with rigor and accuracy.
  • Interpersonal and collaborative skills to work effectively in cross-functional teams and present results to diverse audiences.
  • A record of innovative algorithm and model development demonstrated through impactful publications, patents, or widely adopted tools.

Responsibilities

  • Develop and apply advanced methodologies at the intersection of functional genomics and artificial intelligence/machine learning analytics to identify and validate novel therapeutic targets, elucidate mechanisms of action, and discover preclinical biomarkers.
  • Provide computational and data science support for high-throughput single-cell perturbation and phenotypic screening experiments, such as Perturb-seq, to map gene–phenotype relationships, uncover disease drivers, and prioritize hits for validation.
  • Identify gaps in analytical workflows and develop robust, reproducible, and FAIR solutions that improve data interpretability, strengthen readout confidence, and accelerate therapeutic hypothesis generation.
  • Build and apply machine learning, deep learning, and generative artificial intelligence approaches to simulate cellular responses to single or combinatorial genetic and non-genetic perturbations, delivering fit-for-purpose predictions that reduce experimental burden and accelerate therapeutic hypothesis generation.
  • Collaborate with experimental biologists and translational teams to ensure computational predictions align with experimental design and biological context, enabling testable target and biomarker hypotheses.
  • Contribute to the design of perturbation experiments so computational and experimental approaches inform and strengthen each other.

Desired Qualifications

  • Experience with single-cell omics technologies is ideal.
  • Experience with in silico modeling of cellular responses to drug or genetic perturbations is ideal.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs